13F

Stock

Tarsus Pharmaceuticals, Inc.

TARS · held by 3 managers

Reported value

$4.38M

Holders

3

+1 new · −0 exited

Holders’ est. mark

$1.68M

Price effect on 1 books still in the name

Largest holder

$4.13M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC74.7K$4.13M$1.68MAdded$889.1K
Marex Group plc4.4K$243.6KNew
Catherine Avery Investment Management LLC20$1.11KHeld

Positions as of Q4 2024. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.